Literature DB >> 3760140

Comparison by studies in squirrel monkeys, chimpanzees, and adult humans of avian-human influenza A virus reassortants derived from different avian influenza virus donors.

M H Snyder, M L Clements, D Herrington, W T London, E L Tierney, B R Murphy.   

Abstract

We evaluated the abilities of three different avian influenza A viruses to attenuate the wild-type human influenza A/Korea/1/82 (H3N2) virus in squirrel monkeys, chimpanzees, and adult seronegative human volunteers. Two of these, avian influenza A/Mallard/NY/78 and A/Mallard/Alberta/76 viruses, appeared to be satisfactory donors of attenuating genes for the production of live influenza A reassortant virus vaccines for human use because the reassortants exhibited an acceptable balance between attenuation and immunogenicity.

Entities:  

Mesh：

Substances：

Year:  1986        PMID： 3760140      PMCID： PMC268939          DOI： 10.1128/jcm.24.3.467-469.1986

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  10 in total

1.  Dose response of influenza A/Washington/897/80 (H3N2) avian-human reassortant virus in adult volunteers.

Authors:  B R Murphy; M L Clements; E L Tierney; R E Black; J Stienberg; R M Chanock
Journal:  J Infect Dis       Date:  1985-07       Impact factor: 5.226

2.  Comparison of long-term systemic and secretory antibody responses in children given live, attenuated, or inactivated influenza A vaccine.

Authors:  P R Johnson; S Feldman; J M Thompson; J D Mahoney; P F Wright
Journal:  J Med Virol       Date:  1985-12       Impact factor: 2.327

3.  Dose response of A/Alaska/6/77 (H3N2) cold-adapted reassortant vaccine virus in adult volunteers: role of local antibody in resistance to infection with vaccine virus.

Authors:  M L Clements; S O'Donnell; M M Levine; R M Chanock; B R Murphy
Journal:  Infect Immun       Date:  1983-06       Impact factor: 3.441

4.  Secretory and systemic immunological response in children infected with live attenuated influenza A virus vaccines.

Authors:  B R Murphy; D L Nelson; P F Wright; E L Tierney; M A Phelan; R M Chanock
Journal:  Infect Immun       Date:  1982-06       Impact factor: 3.441

5.  Temperature-sensitive mutants of influenza virus. 3. Further characterization of the ts-1(E) influenza A recombinant (H3N2) virus in man.

Authors:  B R Murphy; E G Chalhub; S R Nusinoff; J Kasel; R M Chanock
Journal:  J Infect Dis       Date:  1973-10       Impact factor: 5.226

6.  Avian-human reassortant influenza A viruses derived by mating avian and human influenza A viruses.

Authors:  B R Murphy; A J Buckler-White; W T London; J Harper; E L Tierney; N T Miller; L J Reck; R M Chanock; V S Hinshaw
Journal:  J Infect Dis       Date:  1984-12       Impact factor: 5.226

7.  Cold-adapted variants of influenza A virus: evaluation in adult seronegative volunteers of A/Scotland/840/74 and A/Victoria/3/75 cold-adapted recombinants derived from the cold-adapted A/Ann Arbor/6/60 strain.

Authors:  B R Murphy; H P Holley; E J Berquist; M M Levine; S B Spring; H F Maassab; A P Kendal; R M Chanock
Journal:  Infect Immun       Date:  1979-02       Impact factor: 3.441

8.  Evaluation of live avian-human reassortant influenza A H3N2 and H1N1 virus vaccines in seronegative adult volunteers.

Authors:  M H Snyder; M L Clements; R F Betts; R Dolin; A J Buckler-White; E L Tierney; B R Murphy
Journal:  J Clin Microbiol       Date:  1986-05       Impact factor: 5.948

9.  Virulence of avian influenza A viruses for squirrel monkeys.

Authors:  B R Murphy; V S Hinshaw; D L Sly; W T London; N T Hosier; F T Wood; R G Webster; R M Chanock
Journal:  Infect Immun       Date:  1982-09       Impact factor: 3.441

10.  Evaluation of avian-human reassortant influenza A/Washington/897/80 x A/Pintail/119/79 virus in monkeys and adult volunteers.

Authors:  M L Clements; M H Snyder; A J Buckler-White; E L Tierney; W T London; B R Murphy
Journal:  J Clin Microbiol       Date:  1986-07       Impact factor: 5.948
  10 in total
  10 in total

1.  Validation of the wild-type influenza A human challenge model H1N1pdMIST: an A(H1N1)pdm09 dose-finding investigational new drug study.

Authors:  Matthew J Memoli; Lindsay Czajkowski; Susan Reed; Rani Athota; Tyler Bristol; Kathleen Proudfoot; Sarah Fargis; Matthew Stein; Rebecca L Dunfee; Pamela A Shaw; Richard T Davey; Jeffery K Taubenberger
Journal:  Clin Infect Dis       Date:  2014-11-20       Impact factor: 9.079

2.  Comparison of the virologic and immunologic responses of volunteers to live avian-human influenza A H3N2 reassortant virus vaccines derived from two different avian influenza virus donors.

Authors:  M L Clements; S D Sears; K Christina; B R Murphy; M H Snyder
Journal:  J Clin Microbiol       Date:  1989-01       Impact factor: 5.948

3.  The avian influenza virus nucleoprotein gene and a specific constellation of avian and human virus polymerase genes each specify attenuation of avian-human influenza A/Pintail/79 reassortant viruses for monkeys.

Authors:  M H Snyder; A J Buckler-White; W T London; E L Tierney; B R Murphy
Journal:  J Virol       Date:  1987-09       Impact factor: 5.103

4.  Evaluation of anti-influenza effects of camostat in mice infected with non-adapted human influenza viruses.

Authors:  M G Lee; K H Kim; K Y Park; J S Kim
Journal:  Arch Virol       Date:  1996       Impact factor: 2.574

Review 5.  The use of nonhuman primates in research on seasonal, pandemic and avian influenza, 1893-2014.

Authors:  A Sally Davis; Jeffery K Taubenberger; Mike Bray
Journal:  Antiviral Res       Date:  2015-03-05       Impact factor: 5.970

6.  Use of single-gene reassortant viruses to study the role of avian influenza A virus genes in attenuation of wild-type human influenza A virus for squirrel monkeys and adult human volunteers.

Authors:  M L Clements; E K Subbarao; L F Fries; R A Karron; W T London; B R Murphy
Journal:  J Clin Microbiol       Date:  1992-03       Impact factor: 5.948

7.  Phylogenetic analysis of H7 avian influenza viruses isolated from the live bird markets of the Northeast United States.

Authors:  D L Suarez; M Garcia; J Latimer; D Senne; M Perdue
Journal:  J Virol       Date:  1999-05       Impact factor: 5.103

8.  Acquisition of a polybasic hemagglutinin cleavage site by a low-pathogenic avian influenza virus is not sufficient for immediate transformation into a highly pathogenic strain.

Authors:  Olga Stech; Jutta Veits; Siegfried Weber; Daniela Deckers; Diana Schröer; Thomas W Vahlenkamp; Angele Breithaupt; Jens Teifke; Thomas C Mettenleiter; Jürgen Stech
Journal:  J Virol       Date:  2009-03-18       Impact factor: 5.103

Review 9.  The pathology of influenza virus infections.

Authors:  Jeffery K Taubenberger; David M Morens
Journal:  Annu Rev Pathol       Date:  2008       Impact factor: 23.472

10.  Comparisons of highly virulent H5N1 influenza A viruses isolated from humans and chickens from Hong Kong.

Authors:  D L Suarez; M L Perdue; N Cox; T Rowe; C Bender; J Huang; D E Swayne
Journal:  J Virol       Date:  1998-08       Impact factor: 5.103
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.